|
|
|
|
|
CUSIP No. 448451104
|
|
|
|
Page
6
of 8 Pages
|
|
Item 5.
|
Interest in Securities of the Issuer
|
(a, b) The percentages of beneficial ownership reported in this Item 5, and on each Reporting Persons cover page to this
Schedule 13D, are based on a total of 27,417,819 shares of the Common Stock issued and outstanding as of March 1, 2021, as reported in the definitive proxy statement of the Issuer dated March 15, 2021. All of the share numbers reported below, and on
each Reporting Persons cover page to this Schedule 13D, are as of March 29, 2021, unless otherwise indicated. The cover page to this Schedule 13D for each Reporting Person is incorporated by reference in its entirety into this Item 5(a,
b).
The Fund directly holds, and thus has sole voting and dispositive power over, 2,293,560 shares of Common Stock. The
GP, as sole general partner of the Fund, also has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund, and Mr. Lynch has shared authority to vote (or direct the vote
of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Accordingly, each of the Reporting Persons beneficially owns 2,293,560 shares of Common Stock, or approximately 8.4% of the outstanding shares of Common Stock, and
the Reporting Persons beneficially own, in the aggregate, 2,293,560 shares of Common Stock, or approximately 8.4% of the outstanding shares of Common Stock.
(c) Except as otherwise described in this Schedule 13D, no Reporting Person, other than the Fund as set forth in the table
below, effected any transaction in shares of the Common Stock during the period (the Reporting Period) from January 28, 2021 (the date 60 days prior to the filing of this Schedule 13D) to March 29, 2021:
|
|
|
|
|
|
|
|
|
Date of Purchase
|
|
Shares
Purchased (#)
|
|
|
Purchase Price
per Share ($)
|
|
3/4/2021
|
|
|
17,328
|
|
|
$
|
3.4334
|
|
3/5/2021
|
|
|
1,500
|
|
|
$
|
3.3043
|
|
3/8/2021
|
|
|
2,000
|
|
|
$
|
3.3953
|
|
3/10/2021
|
|
|
1,000
|
|
|
$
|
3.428
|
|
3/23/2021
|
|
|
41,365
|
|
|
$
|
3.4978
|
|
3/24/2021
|
|
|
13,190
|
|
|
$
|
3.4789
|
|
3/25/2021
|
|
|
11,401
|
|
|
$
|
3.4232
|
|
3/26/2021
|
|
|
1,515
|
|
|
$
|
3.4800
|
|
3/29/2021
|
|
|
16,319
|
|
|
$
|
3.4960
|
|
The above listed transactions were conducted in the ordinary course of business on the open market for cash.
The purchase prices do not reflect brokerage commissions paid.
In addition, during the Reporting Period, the Fund sold the standard
American-style, exchange-traded put options described in Item 6, which is incorporated by reference into this Item 5(c).
4. Item 6 of the Schedule 13D
shall hereby be amended by inserting the following at its beginning:
The table below lists the standard American-style, exchange-traded
put options (Put Options) sold by the Fund during the Reporting Period, all of which are outstanding as of March 29, 2021. Each of the below listed transactions was conducted in the ordinary course of business on the open
market for cash, and the sale prices do not reflect brokerage commissions paid.